German pharmaceutical company Boehringer Ingelheim GmbH misled consumers and doctors about the safety and efficacy of Mirapex, the restless-leg syndrome treatment, according to the U.S. Food and Drug Administration.
A cigarette manufacturer has lost a round in its bid to depose attorneys general in an antitrust case involving escrow money, which states require in order to ensure payment in the event a tobacco maker is found liable for health hazards associated with smoking.
A trial lawyers' association has accused the Bush administration of rewriting a slew of federal rules to preempt state laws that protect consumers, as part of a campaign to shield corporations from product liability lawsuits.
Lawmakers are probing whether the chairman of a panel advising the U.S. Food and Drug Administration on the safety of bisphenol A, a chemical widely used in plastic products, was compromised by a $5 million donation made to his research center by a donor who has vouched for the controversial chemical's safety.
A federal judge has granted Bayer Corp. summary judgment and dismissed 37 plaintiffs from one case in the multidistrict litigation over Baycol, ruling that the claimants failed to demonstrate that the cholesterol-lowering drug caused their ailments.
U.S. Democratic lawmakers have furthered the probe into a Bayer AG medication that combines Aspirin with plant-based supplements and that the company claims can lower bad cholesterol.
In a ruling that could have implications for so-called patent-shopping cases in Texas, a federal appeals court on Friday ordered a product liability case against Volkswagen of America Inc. moved out of the plaintiff-friendly Eastern District of Texas into the Dallas Division of the Northern District of Texas.
A federal judge has thrown out a proposed class action against big oil firms, including Exxon Mobil Corp. and ConocoPhillips Co., that alleged their ethanol-blended gasoline caused damage to boat fuel tanks and engines.
In its first blanket recall in the melamine scandal, the government of China has recalled all liquid and powdered milk made before Sept. 14 — ordering the products to be tested for contamination from the chemical additive.
Tossing aside objections, the federal judge overseeing the multidistrict pet food litigation has issued final approval of a $24 million settlement that seeks to put to rest claims over a massive recall of contaminated dog and cat meals last year.
A California state court judge has ruled that Dr. Bronner's Magic Soaps can proceed with its unfair competition lawsuit against several major makers of beauty and skin care products marketed as “organic,” which Dr. Bronner's claims do not meet the standards to be called organic.
A U.S. Food and Drug Administration inspection of a Puerto Rico plant of medical device maker C.R. Bard Inc. revealed a slew of manufacturing problems, the agency revealed in a letter made public Tuesday.
Product liability lawsuits were one of the top 10 most common types of actions faced by U.S. companies this year despite an overall slowing in case filings, according to a survey to be released on Tuesday.
Boston Scientific Corp. has received federal clearance to bring its Taxus Liberte drug-eluting stent to market after waiting more than two years due to regulatory problems at the company’s facilities.
The state of California’s building management department will not be able recover $130 million in asbestos damages from materials company W.R. Grace & Co. because the claims are time-barred, a judge has ruled.
The attorneys general for Connecticut, Delaware and New Jersey have written to 11 companies that manufacture baby bottles and infant formula — including Gerber, Abbott Laboratories and the Walt Disney Co. — asking them to stop using the controversial plastic additive bisphenol A in their products.
The country's largest tobacco companies squared off against the federal government on Tuesday in a bid to overturn a finding that they formed an illegal enterprise and conspired to systematically hide and deny evidence of the harms of smoking for over half a century.
Jaguar Land Rover North America LLC is facing another proposed class action over claims that its LR3 model Land Rovers contain a manufacturing defect that causes premature tire wear.
A Philadelphia jury has ruled in favor of Wyeth Pharmaceuticals Inc. in a wrongful death suit over the diet drug Pondimin, which spurred thousands of lawsuits after Wyeth yanked it off the shelves amid claims that it causes heart disease.
Johnson & Johnson has reportedly racked up at least $68.7 million in its efforts to settle hundreds of lawsuits filed by women who suffered adverse effects after using the Ortho Evra birth control patch.